Concepedia
Publication | Open Access
The Dapagliflozin And Prevention of Adverse-Outcomes in Heart Failure (DAPA-HF) Trial: Baseline Characteristics
217
Citations
31
References
2019
Year
ClinicalTrials.gov Identifier NCT03036124.
Page 1